MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance
Davis, Lorraine N, Walker, Zachary J, Reiman, Lauren T, Parzych, Sarah E, Stevens, Brett M, Jordan, Craig T, Forsberg, Peter A, Sherbenou, Daniel W
Published in Clinical cancer research (15.07.2024)
Published in Clinical cancer research (15.07.2024)
Get full text
Journal Article
Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies
Keller, Alana L, Reiman, Lauren T, Perez de Acha, Olivia, Parzych, Sarah E, Forsberg, Peter A, Kim, Peter S, Bisht, Kamlesh, Wang, Hongfang, van de Velde, Helgi, Sherbenou, Daniel W
Published in Cancer research communications (12.03.2024)
Published in Cancer research communications (12.03.2024)
Get full text
Journal Article
Prolonged Omacetaxine Treatment Alters Fitness and Proteostasis in Multiple Myeloma
Walker, Zachary J, Steinmetz, Rachel N, Ohlstrom, Denis J, Reiman, Lauren T, Mills, Taylor S, Idler, Beau M, Stevens, Brett M., Pietras, Eric, Sherbenou, Daniel W.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
High Ex Vivo Response Rates to CD38/CD28xCD3 Trispecific T Cell Engager in Patients Relapsed after Anti-CD38 and Anti-BCMA Targeted Immunotherapies
Keller, Alana, Perez De Acha, Olivia, Reiman, Lauren T, Walker, Zachary J, Jayabalan, David S, Niesvizky, Ruben, Forsberg, Peter A, Kim, Peter, Bisht, Kamlesh, Wang, Hongfang, van de Velde, Helgi, Sherbenou, Daniel W.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article